EUVIMEDEUVIMED entdecken
Crossref

Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+

Xue-Xia Yuan, You-Fa Duan, Chunxiang Luo, Lu Li, Meng-Jie Yang, Ting-Yu Liu, Zhi-Rui Cao, Wenlin Huang, Xianzhang Bu, Xin Yue, Ran-Yi Liu

Biochemical Pharmacology · 2023

DOI: 10.1016/j.bcp.2023.115498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023. Verfasst von Xue-Xia Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the use of targeted therapy in non-small cell lung cancer (NSCLC) patients, cisplatin (DDP)-based chemotherapy is still the main option. However, DDP resistance is the major factor contributing to the failure of chemotherapy. In this study, we tried to screen DDP sensitizers from an FDA-approved drug library containing 1374 small-molecule drugs to overcome DDP resistance in NSCLC. As a result, disulfiram (DSF) was identified as a DDP sensitizer: DSF and DDP had synergistic anti-NSCLC effects, which are mainly reflected in inhibiting tumor cell proliferation, plate colony formation and 3D spheroidogenesis and inducing apoptosis in vitro, as well as the growth of NSCLC xenografts in mice. Although DSF has recently been reported to promote the antitumor effect of DDP by inhibiting ALDH activity or modulating some important factors or pathways, unexpectedly, we found that DSF reacted with DDP to form a new platinum chelate, Pt(DDTC)3+, which might be one of the important mechanisms for their synergistic effect. Moreover, Pt(DDTC)3+ has a stronger anti-NSCLC effect than DDP, and its antitumor activity is broad-spectrum. These findings reveal a novel mechanism underlying the synergistic antitumor effect of DDP and DSF, and provide a drug candidate or a lead compound for the development of a new antitumor drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsHumansMiceAnimalsCisplatinDisulfiramPlatinumCell ProliferationDrug Resistance, NeoplasmCell Line, Tumor

Stichwörter der Autor:innen

CisplatinDisulfiramNon-small cell lung cancerPlatinum(IV) chelatePt(DDTC)(3)(+)

Substanzen

CisplatinDisulfiramPlatinumAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; Zhongshan School of Medicine, Sun Yat-sen University,…
  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, Guangdong, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; Department of Traditional Chinese Medicine, The First…
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; Guangdong Provincial Key Laboratory of Tumor Targeted…

Förderung

  • National Natural Science Foundation of China
  • Department of Science and Technology of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Yuan, X. X., Duan, Y. F., Luo, C., Li, L., Yang, M. J., Liu, T. Y., Cao, Z. R., Huang, W., Bu, X., Yue, X., & Liu, R. Y. (2023). Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2023.115498

Vancouver

Yuan XX, Duan YF, Luo C, Li L, Yang MJ, Liu TY, et al. Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+. Biochemical Pharmacology. 2023. doi:10.1016/j.bcp.2023.115498

BibTeX
@article{Yuan2023,
  author = {Yuan, Xue-Xia and Duan, You-Fa and Luo, Chunxiang and Li, Lu and Yang, Meng-Jie and Liu, Ting-Yu and Cao, Zhi-Rui and Huang, Wenlin and Bu, Xianzhang and Yue, Xin and Liu, Ran-Yi},
  title = {Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+},
  journal = {Biochemical Pharmacology},
  year = {2023},
  doi = {10.1016/j.bcp.2023.115498}
}
Kostenlos starten →